Assessment of HIV risk

Journal of Addictive Diseases

Volumn 17, Issue 4, 1998, Pages 49-59

  Chawarski, Marek C ^a   Pakes, Juliana ^a   Schottenfeld, Richard S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CONFERENCE PAPER; DRUG ABUSE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; METHODOLOGY; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; SEXUAL BEHAVIOR; VIRUS TRANSMISSION;

HIV INFECTIONS; HUMANS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK-TAKING; SENSITIVITY AND SPECIFICITY; SUBSTANCE-RELATED DISORDERS;

EID: 0031792525     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v17n04_05     Document Type: Article

References (34)

1. Edlin BR, Irwin KL, Faruque S, McCoy CB, Word C, Serrano Y, Inciardi JA, Bowser BP, Schilling KF, Holmberg SD. Intersecting epidemics-crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. NEngl J Med. 1994;331(21): 1422-7.
2. Lehman JS, Allen DM, Green TA, Onorato IM HIV infection among non-injecting drug users entering drug treatment, United States, 1989-1992. Field Services Branch. Aids. 1994;8(10):1465-9.
3. Goedert JJ, Pizza G, Gritti FM, Costigliola P, Boschini A, Bini A, Lazzari C, Palareti A. Mortality among drug users in the AIDS era. Int J Epidemiol. 1995;24(6): 1204-10.
4. Allen DM, Onorato IM, Green TA. HIV infection in intravenous drug users entering drug treatment, United States, 1988 to 1989. The Field Services Branch of the Centers for Disease Control. Am J Public Health. 1992;82(4):541-6.
5. Anonumous. HIV/AIDS Surveillance: US AIDS cases reported through December 1994. Atlanta, GA: Centers for Disease Control and Prevention; 1995.
6. Iguchi MY, Platt JJ, French JF, Baxter RC, Kushner H, Lidz VM, Bux DA, Rosen M, & Musikoff H. Correlates of HTV seropositivity among intravenous drug users not in treatment. Journal of Dmg Issues. 1992;22:849-866.
7. Iguchi MY, Bux DA, Lidz V, Kushner H, French JF, Platt JJ. Interpreting HIV seroprevalence data from a street-based outreach program. J Acquir Immune Defic Syndr. 1994;7(5):491-9.
8. Bux DA, Lamb RJ, Iguchi MY. Cocaine use and HTV risk behavior in methadone maintenance patients. Drug Alcohol Depend. 1995;37(l):29-35.
9. Dwyer R, Richardson D, Ross MW, Wodak A, Miller ME, Gold J. A comparison of HIV risk between women and men who inject drugs. AIDS Educ Prev. 1994; 6(5):379-89.
10. Grella CE, Anglin MD, Wugalter SE. Cocaine and crack use and HTV risk behaviors among high-risk methadone maintenance clients. Drug Alcohol Depend. 1995;37(1):15-21.
11. Hudgins R, McCusker J, Stoddard A. Cocaine use and risky injection and sexual behaviors. Drug Alcohol Depend. 1995;37(1):7-14.
12. Iguchi MY, Bux DA, Jr., Kushner H, Lidz V, French JF, Platt JJ. Prospective evaluation of a model of risk for HTV infection among injecting dmg users. Dmg Alcohol Depend. 1995;40(1):63-71.
13. Joe GW, Simpson DD. HIV risks, gender, and cocaine use among opiate users. Drug Alcohol Depend. 1995;37(l):23-8.
14. Kail K. The risk of HTV infection for noninjecting sex partners of injecting dmg users in Stockholm. AIDS Educ Prev. 1994;6(4):351-364.
15. Tortu S, Beardsley M, Deren S, Davis WR The risk of HIV infection in a national sample of women with injection drug-using partners. Am J Public Health. 1994;84(8): 1243-9.
16. Wodak AD, Stowe A, Ross MW, Gold J et al. HIV risk exposure of injecting drug users in Sydney. Drug & Alcohol Review. 1995;14:213-222.
17. Zapata V, Blanton C. AIDS and intravenous drug use: a growing menace. J DrugEduc. 1994;24(2): 133-8.
18. Compton WM, Lamb RJ, Fletcher BW. Results of the NIDA treatment demonstration grants’ cocaine workgroup: characteristics of cocaine users and HIV risk behaviors. Drug Alcohol Depend. 1995;37(1): 1-6.
19. Inciardi JA, Tims FM, & Fletcher BW, ed. Innovative Approaches in the Treatment of Dmg Abuse. Westport, CT: Greenwood Press; 1993.
20. Irwin KL, Edlin BR, Faruque S, McCoy HV, Word C, Serrano Y, Inciardi J, Bowser B, Holmberg SD. Ciack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Cfack Cocaine and HIV Infection Study Team. Drug Alcohol Depend. 1996;42(2):85-92.
21. Greenfield L, Bigelow GE, Brooner RK. Validity of intravenous drug abusers’ self-reported changes in HIV high-risk drug use behaviors. Drug Alcohol Depend. 1995;39(2):91-8.
22. Wells EA, Clark LL, Calsyn DA, Saxon AJ, Jackson TR, Wrede AF. Reporting of HIV risk behaviors by injection dmg using heterosexual couples in methadone maintenance. Dmg Alcohol Depend. 1994;36(l):33-8.
23. Darke S, Hall W, Heather N, Ward J, Wodak A. The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous dmg users. Aids. 1991;5(2):181-5.
24. Metzger DS, DePhilippis D, Dmley P, O’Brien CP, McLellan AT, Williams J, Navaline H, Dyanick S, Woody GE. The Impact of HIV Testing on Risk for AIDS Behaviors. In: Harris L, ed. College on Problems of Drug Dependence, 58th Annual Scientific Meeting; 1991:297-298.
25. Longshore D, Hsieh SC, Anglin MD. Reducing HIV risk behavior among injection dmg users: effect of methadone maintenance treatment on number of sex partners. Int J Addict. 1994;29(6):741-57.
26. Morrison CS, McCusker J, Stoddard AM, Bigelow C. The validity of behavioral data reported by injection dmg users on a clinical risk assessment. Int J Addict. 1995;30(7):889-99.
27. McKeganey N. Why do men buy sex and what are their assessments of the HIV-related risks when they do? AIDS Care. 1994;6(3):289-301.
28. Watters JK, Estilo MJ, Kral AH, Lorvick JJ. HIV infection among female injection-drug users recruited in community settings. Sex Transm Dis. 1994;21 (6): 321-8.
29. Be vier PJ, Chiasson MA, Heffeman RT, Castro KG. Women at a sexually transmitted disease clinic who reported same-sex contact: their HIV seroprevalence and risk behaviors. Am J Public Health. 1995;85(10):1366-71.
30. McQuillan GM, Khare M, Karon JM, Schable CA, Vlahov D. Update on the seroepidemiology of human immunodeficiency vims in the United States household population: NHANES El, 1988-1994. J Acquir Immune De fie Syndr Hum Retro virol. 1997;14(4):355-60.
31. Jacobson RL, Harris AB, Doyle MG. HIV infection and associated sexually transmitted diseases in women. Tex Med. 1995;91(3):58-60.
32. Lauver D, Armstrong K, Marks S, Schwarz S. HIV risk status and preventive behaviors among 17, 619 women. J Obstet Gynecol Neonatal Nurs. 1995;24(1):33-9.
33. First MB, Spitzer RL, Gibbon M, & Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-patient Edition (SCID-TO), Version 2.0.: Biometrics Research Department, New York State Psychiatric Institute; 1996.
34. Schottenfeld RS, O’Malley S, O’Connor P, & Abdul-Salaam K. Decline in intravenous dmg use among treatment seeking opiate users. Journal of Substance Abuse Treatment. 1993;10:5-10.